Advertisement
Advertisement
ADXN
Addex Therapeutics Ltd - ADR
6.50
USDSponsored
+0.30
+4.82%
Mar 25, 15:22 UTC -4
Closed
Pre-Market
6.14
-0.36
-5.55%
ADXN Earnings Reports
Positive Surprise Ratio
No Data Available for ADXN
0%
Next Report
Date of Next Report
Apr 06, 2026
Estimate for Q4 25 (Revenue/ EPS)
--
/--
Implied change from Q3 25 (Revenue/ EPS)
--
/--
Implied change from Q4 24 (Revenue/ EPS)
--
/--
Addex Therapeutics Ltd - ADR earnings per share and revenue
On Dec 04, 2025, ADXN reported earnings of -- USD per share (EPS) for Q3 25, -- the estimate of -- USD, resulting in a --% surprise. Revenue reached --, compared to an expected --, with a --% difference. The market reacted with a -6.78% price change (close before vs. close after earnings).
Looking ahead to Q4 25, -- analysts forecast an EPS of -- USD, with revenue projected to reach -- USD, implying an -- of --% EPS, and -- of --% in Revenue from the last quarter.
Industry Peers’ Earnings
Industry Peers' Earnings displays EPS earnings data from companies in the same industry. Click on a card to view more details.
Talphera, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.08
Actual
-$0.06
Surprise
+26.47%
Theravance Biopharma, Inc.
Report Date
Mar 19, 2026 For Q4 25
Estimate
$1.24
Actual
$0.21
Surprise
-83.12%
Relmada Therapeutics, Inc. Common Stock
Report Date
Mar 19, 2026 For Q4 25
Estimate
-$0.14
Actual
-$0.28
Surprise
-103.08%
Context Therapeutics Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.10
Actual
-$0.14
Surprise
-29.39%
Avalo Therapeutics, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$1.49
Actual
-$1.12
Surprise
+24.33%
Journey Medical Corporation Common Stock
Report Date
Mar 25, 2026 For Q4 25
Estimate
-$0.05
Actual
-$0.04
Surprise
+31.86%
Surrozen, Inc. Common
Report Date
Mar 30, 2026 For Q4 25
Estimate
-$1.21
Actual
-Surprise
-
Achieve Life Sciences, Inc.
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.27
Actual
-$0.28
Surprise
-1.12%
Pyxis Oncology, Inc. Common Stock
Report Date
Mar 23, 2026 For Q4 25
Estimate
-$0.34
Actual
-$0.28
Surprise
+15.55%
Fractyl Health, Inc. Common Stock
Report Date
Mar 24, 2026 For Q4 25
Estimate
-$0.18
Actual
$0.15
Surprise
+181.70%
FAQ
What were Addex Therapeutics Ltd - ADR's earnings and revenue for the latest quarter Q3 2025?
For Q3 2025, Addex Therapeutics Ltd - ADR reported EPS of --, missing estimates by --, and revenue of --, -- -- expectations.
How did the market react to Addex Therapeutics Ltd - ADR's Q3 2025 earnings?
The stock price moved down -6.78%, changed from $8.99 before the earnings release to $8.38 the day after.
When is Addex Therapeutics Ltd - ADR expected to report next?
The next earning report is scheduled for Apr 06, 2026.
What are the forecasts for Addex Therapeutics Ltd - ADR's next earnings report?
Based on --
analysts, Addex Therapeutics Ltd - ADR is expected to report EPS of -- and revenue of -- for Q4 2025.
Which companies are reporting earnings today?
Check FXEmpire's Earnings Calendar for today's list of reporting companies.
Advertisement